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Abstract: Objective: This study examined racial differences in the self-report of depressive symptoms by reference to 
biological states. 
Methods: The study used a convenience sample of 20 depressed cancer patients (CES-D 16) (15 African Americans and 
5 Whites). Subjects completed depression assessment on a battery of psychological measures and provided blood and 
saliva samples. Laboratory tests were performed on biomarkers (serotonin, cortisol and IL-6). T-test was computed to 
examine racial differences on biological and psychological measures. 
Results: Depressed Whites had a significantly higher cortisol level than depressed African Americans, but no significant 
group difference was found on any self-reported psychological measures of depression. There was a trend that African 
Americans reported fewer depressive symptoms on psychological measures but exceeded Whites on the domain of 
somatization; however, such group differences did not approach statistic significance in this small sample. 
Conclusion: African Americans did not appear to underreport depression in consideration of their biological states, but 
had a tendency to report more somatic symptoms than Whites; this may be attributable to non-depression diseases or 
reporting behavior rather than somatic sensitivity. African Americans exhibited more mistrust in the health care system, 
which could affect the self-report of depression. There is a discord between biological and psychological measures of 
depression. Biomarkers prove to be useful for evaluating racial difference in the self-report of depression. 
Implication for Nursing: Nurses should be cautious of somatic complaints when assessing African American cancer 
patient’s depression. Establishing trust is essential for an accurate assessment of depression in African American cancer 
patients. 
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INTRODUCTION 
  Depression is a significant predictor of cancer survival 
[1, 2]. African Americans have the highest cancer mortality 
and shortest survival after receiving a cancer diagnosis 
among all racial and ethnic groups in the United States [3]. 
Understanding racial difference in self-report is essential for 
improving depression assessment in this underserved population. 
  Existing literature suggests a racial difference in the 
presentation of depressive symptoms. Depressed African 
Americans complained more frequently than depressed white 
Americans about somatic symptoms, including poor appetite, 
fatigue, psychomotor retardation and sleep disturbance [4, 
5]. The findings may indicate that African Americans have 
heightened somatic sensitivity or verbally amplify physical 
sickness sensations in self-report [6]. A competing theory, 
however, is that depressed African Americans are sicker than 
depressed white Americans due to an unequal burden of 
chronic illness [7]. 
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  The literature has also shown that depressed African 
Americans report fewer negative emotions than depressed 
white Americans [4, 8]. For example, Gary and Yarandi 
reported [2004] that the factor loading of affective items in 
the BDI-II was lower than that of somatic and cognitive 
items among 206 healthy AA women. Brown et al. [9, 10] 
described depressed moods to be not as blatant as other 
depressive symptoms in AA women. Whether this observed 
“flat affect” in African Americans is an accurate account or a 
filtered presentation of biopsychological states remains 
unknown. 
  To assess racial difference in the manifestation of 
depressive symptoms by reference to the biological 
underpinnings is important, particularly for patients with a 
malignant tumor. Cancer-related symptoms including 
fatigue, decreased psychomotor activity, poor sleep and 
change in appetite resemble vegetative symptoms of 
depression [11, 12], making the detection of depression more 
difficult. Modern science has identified a number of 
biological markers for assessing depression. Low serotonin 
has been earmarked for depressive emotions [13]; high 
cortisol is frequently used as an indicator of mental stress 
[14]. On the other hand, high plasma Il-6 concentration and 
immunosuppression [e.g., decreased NK cell activity and   
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proliferation responses of lymphocytes] were reported to be 
associated with depression in cancer patients [15, 16]. These 
biomarkers can provide a biological baseline for evaluating 
racial differences in the self-report of depressive symptoms. 
Therefore, we collected biomarkers from a small group of 
cancer patients who were participating in a study of cancer-
related depression. The goal was to examine racial 
differences in biological and psychological measures to shed 
light on the self-report of depression. 
MATERIALS AND METHODOLOGY 
  The study was conducted in Cleveland, Ohio in 2008 
with institutional IRB approval. Subject eligibility included a 
diagnosis of early-stage (I-III) breast or prostate cancer 
within the past 3 years, having completed cancer treatments 
for at least 6 months and not having a psychotic disorder. 
Having identified potentially eligible patients through a 
hospital tumor registry and obtaining physicians’ permission, 
an introductory letter and consent were mailed to the 
patients. Research staff followed this up with a call to 
introduce the study and used the Center for Epidemiologic 
Studies-Depression Scale (CES-D) to screen for depression. 
Seventy-five patients were recruited for a parental study of 
depression, of whom 30 depressed participants (CES-D  16) 
were invited to provide biological specimen and 21 
consented at a rate of 70%. Fifteen African Americans and 
five Whites completed study procedure. 
  At a scheduled face-to-face interview, written consent 
was obtained and standard depression instruments were 
administered including the Hamilton Rating Scale for 
Depression (HAM-D), a commonly used and observer-rated 
17-item scale; the Beck Depression Inventory-II (BDI-II), a 
21-item self-rating scale known for its emphasis on affective 
symptoms of depression; the Brief Symptom Inventory (BSI), 
a 53-item self-rating symptom scale; and the Group-Based 
Medical Mistrust Scale (GBMMS), a 12-item scale that 
assesses medical mistrust in health care system and treatment 
provision. 
  Blood was drawn in the hospital immediately after the 
completion of questionnaires. The obtained blood sample 
was centrifuged before it was sent to a laboratory. The 
participants were taught how to obtain a saliva sample and 
provided with a testing kit. They took a saliva sample of free 
cortisol between 7-9 a.m. and then between 9-11 p.m. at 
home, stored them in a fridge and returned them the next day 
using a provided mailing label. Laboratory tests were 
performed on blood and saliva samples in the hospital to 
measure serotonin, cortisol and IL-6. The participants 
received $35 for completing the interview and $30 for 
providing biological specimen. 
  Two research assistants entered data independently using 
the Statistical Package for the Social Sciences (SPSS) 
version 19.0. Any discrepancies between the two SPSS data 
files were resolved by checking the original coding on the 
hard copy to ensure data entry consistency. 
RESULTS 
  T-test and Fisher’s exact test did not detect any 
significant difference between depressed African American 
and White groups in terms of age (mean age = 58 or 59, 
respectively), gender (40% vs 60% female), education (73% 
vs 60% non-college), income (46% vs 20% <$50,000), 
cancer treatment (47% vs 100% for surgery, 67% vs 60% for 
radiation and 27% vs 20% for chemotherapy), a depression 
diagnosis prior to cancer (20% vs 0), comorbidity (mean 
number of disease = 7 and 5 respectively), medications 
(mean number of medication = 6 and 4) and pain in last 24 
hours (mean rating = 5 and 3, respectively), despite some 
across-group variations. There was a tangible and 
insignificant difference between groups in the employment 
status (60% vs 20% unemployed, p=.11). The group 
difference in marital status was marginally significant (p = 
.07) with more Whites (80%) than African Americans (27%) 
being married. The lack of statistic significance was due to 
the small sample size and low statistic power (Table 1). 
  The level of morning cortisol was nearly twice as high in 
depressed Whites as in depressed African Americans, and 
this group difference was significant (p=.036). There was a 
trend of lower serotonin, IL-6 and evening cortisol in the 
White group, but the group difference did not approach 
statistic significance. 
  The mean scores on psychological measures (CES-D, 
HAM-D, BDI-II, BSI and PSSI) were slightly higher in the 
White group, but not significantly different between groups. 
On the contrary, the African American group reported a 
significantly higher mean score on GBMMS-Suspicion 
domain (p=.032) and slightly higher but not significantly 
different mean scores on the BSI-Somatic domain than the 
White group (Table 2). 
DISCUSSION 
  The significantly higher level of morning cortisol 
suggests that the White group experienced severer acute 
stress than the African American group in this study. The 
psychological measures of depression, however, did not 
discern any significant group difference, demonstrating a 
discrepancy between biomarkers and psychological measures 
of depression. Perhaps psychological measures are less 
sensitive to biological states or not conducive to capturing 
acute stress. In any case, we did not find evidence of African 
Americans’ underreporting of depressive symptoms, or the 
so-called “flat affect,” because in contrast with biological 
findings, there was little racial difference in the self-report of 
depression on psychological measures. 
  Of note is the African American group’s insignificant, 
slightly higher score on BSI’s somatization subscale. In this 
study the African American group had lower morning 
cortisol and higher serotonin than the White group or, in 
other words, a better biological state; this contradicts their 
self-report of more somatic symptoms. It is inconceivable 
that African Americans’ somatic complaint originated from 
heightened bodily sensations of depression since they 
experienced less stress, but the finding does not exclude the 
possibility that such a complaint was related to diseases 
other than depression. 
  Existing literature indicates greater mistrust of the health 
care system among African Americans [17]. Consistent with 
the literature, the African American group in this study 
reported significantly greater mistrust in the health care 
system and professionals than the White group. Medical 
mistrust has an origin in cultural belief and life experiences 
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has an influence on African Americans’ self-report of 
depression. 
  Overall, the observed discord between biological and 
psychological measures is not surprising but worth noting. 
Using biomarkers introduces a frame of reference for 
assessing racial difference in the self-report of depressive 
symptoms, particularly in cancer patients whose 
psychobiological states are impinged by both mental and 
physical diseases. The study findings suggest that African 
Americans’ tendency to report more somatic symptoms is 
attributable to a reporting behavior or comorbidity rather 
than heightened somatic sensitivity. The study found no 
evidence for African Americans’ underreporting of affective 
symptoms of depression, but this may be due to a small 
sample size and low statistical power. 
  The study sample size posts a major limitation to the 
interpretation of the study findings. When a study sample is 
as small as the White group in this study, a single extreme 
score can easily sway the group’s mean score, making the 
difference between groups larger or smaller than expected. 
Therefore, findings from this study must be interpreted with 
caution and require replication with a larger study sample. A 
low statistic power associated with the small sample size 
limited the use of multivariate analysis. Study findings that 
were obtained from bivariate tests may be explained by 
demographic differences between groups rather than race. 
Table 1.  Sample Demographics 
 
Variable  Depressed African 
Americans (n=15) 
Depressed Whites (n=5)  p 
 N  %  N  %   
Gender          
Female 6  40%  3  60%  .62 
Marital status           
Married   4  27%  4  80%  .07 
Single 3  20  1  20   
Other (widowed, divorced etc.)  8  53  0  0   
Education          
High school  3  20%  1  20%  .79 
Some college  8  53  2  40   
College 3  20  2  40   
Unknown 1  7  0  0   
Employment          
Full time   4  27%  3  60%  .11 
Half time  0  0  1  20   
Unemployed 9  60  1  20   
Unknown 2  13  0  0   
Income (optional)           
<$25000 (household)  5  33%  0  0  .20 
<$50,000 2  13  1  20%   
$50,000 1  7  2  40   
Unknown 7  47  2  40   
Prior depression diagnosis  3  20%  0  0  .54 
Had surgery  7  47%  5  100%  .14 
Had radiation  10  67%  3  60%  1.0 
Had chemotherapy  4  27%  1  20%  1.0 
  Mean S.D.  Mean  S.D.  p 
Age 58.2  7.2  59.2  9.7  .81 
Number of disease  6.5  4.4  4.8  1.5  .47 
Number of medication  5.6  2.5  3.6  3.6  .18 
Pain within 24 hours (0-10pt)  5.1  3.1  2.8  2.8  .17 Using Biomarkers for Depression Assessment in African Americans  The Open Nursing Journal, 2011, Volume 5    63 
We also found that three White and two African American 
cancer patients used antidepressants to improve mood, while 
we had missing data on many others in this respect. The 
impact of antidepressants on psychological and biological 
measures of depression has yet to be understood. Despite 
these study limitations, this study provided intriguing results 
and some interesting trends, which warrant further 
investigation. It demonstrates the recruitment rate (70%) and 
feasibility of conducting a biomarker study with minority 
cancer patients. It also provided preliminary data that may 
help with future sample size and power estimation. 
CONCLUSION 
  The study findings are preliminary. They shed light on a 
discord between psychological and biological measures of 
depression, the usefulness of depression biomarkers and 
potential racial difference in the manifestation of depression. 
The implications are that nurses need to be cautious of 
somatic complaints that may be concomitants of other 
chronic conditions at the time of assessing African American 
cancer patients’ depression. It is also important to keep in 
mind that cancer treatment brings about significant long-
term side effects such as urinary incontinence, loss of sexual 
desire and erection dysfunction, which are physically taxing, 
psychologically stressful and yet too embarrassing to 
discuss. Nurses need to be able to talk openly with African 
American cancer patients about these issues to identify the 
source of somatic complaints and mental stress. Establishing 
trust is essential for accessing African American cancer 
patients’ emotions and ensuring an accurate assessment of 
depression in this underserved patient population. 
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